Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro
出版年份 2022 全文链接
标题
Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro
作者
关键词
-
出版物
BIOMACROMOLECULES
Volume 23, Issue 7, Pages 2976-2988
出版商
American Chemical Society (ACS)
发表日期
2022-06-24
DOI
10.1021/acs.biomac.2c00469
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Delivery strategies of RNA therapeutics to leukocytes
- (2022) Dana Tarab-Ravski et al. JOURNAL OF CONTROLLED RELEASE
- Drug delivery systems for RNA therapeutics
- (2022) Kalina Paunovska et al. NATURE REVIEWS GENETICS
- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Marginal zone B cells: From housekeeping function to autoimmunity?
- (2021) Anna-Karin E. Palm et al. JOURNAL OF AUTOIMMUNITY
- An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
- (2021) Ole A. W. Haabeth et al. ACS Central Science
- Non-liver mRNA Delivery
- (2021) David Loughrey et al. ACCOUNTS OF CHEMICAL RESEARCH
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- Putative role of marginal zone B cells in pathophysiological processes
- (2020) Dragan Marinkovic et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Morpholino Analogues of Fingolimod as Novel and Selective S1P1 Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis
- (2020) Bisera Stepanovska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes
- (2020) Wei-Ting Chang et al. MOLECULES
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
- (2020) Maria L. Guevara et al. Frontiers in Chemistry
- Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy
- (2020) Aaron J. Wilk et al. Blood Advances
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
- (2020) Cole J. Batty et al. ADVANCED DRUG DELIVERY REVIEWS
- The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
- (2019) Jessica B. Foster et al. MOLECULAR THERAPY
- Local delivery of OX40L, CD80, and CD86 mRNA kindles global anti-cancer immunity.
- (2019) Ole Audun Werner Haabeth et al. CANCER RESEARCH
- Oligo(serine ester) Charge-Altering Releasable Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery
- (2019) Nancy L. Benner et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
- (2019) Jihye Yoo et al. Cancers
- Ligand‐Installed Nanocarriers toward Precision Therapy
- (2019) Peng Mi et al. ADVANCED MATERIALS
- Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis
- (2019) Claudia Volpi et al. Expert Opinion on Drug Discovery
- Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process
- (2019) Azadeh Yazdi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- CD177-mediated nanoparticle targeting of human and mouse neutrophils
- (2018) Heini M. Miettinen et al. PLoS One
- Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
- (2018) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
- (2018) Ole A. W. Haabeth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways
- (2018) Alan Baer et al. Scientific Reports
- A Novel Platform for Cancer Vaccines: Antigen-Selective Delivery to Splenic Marginal Zone B Cells via Repeated Injections of PEGylated Liposomes
- (2018) Taro Shimizu et al. JOURNAL OF IMMUNOLOGY
- GalNAc bio-functionalization of nanoparticles assembled by electrostatic interactions improves siRNA targeting to the liver
- (2017) Efrat Korin et al. JOURNAL OF CONTROLLED RELEASE
- Altered Marginal Zone B Cell Selection in the Absence of IκBNS
- (2017) Monika Ádori et al. JOURNAL OF IMMUNOLOGY
- Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
- (2017) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
- (2016) Kevin J. Kauffman et al. BIOMATERIALS
- Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity
- (2016) F L Scott et al. BRITISH JOURNAL OF PHARMACOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation
- (2016) Carolina V. Messias et al. PLoS One
- Homeostatic ‘bystander’ proliferation of human peripheral blood B cells in response to polyclonal T-cell stimulationin vitro
- (2015) Aleksandra Jasiulewicz et al. INTERNATIONAL IMMUNOLOGY
- Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice
- (2014) Faik Imeri et al. NEUROPHARMACOLOGY
- The Spleen in Local and Systemic Regulation of Immunity
- (2013) Vincenzo Bronte et al. IMMUNITY
- Galactose-Functionalized Cationic Polycarbonate Diblock Copolymer for Targeted Gene Delivery to Hepatocytes
- (2013) Zhan Yuin Ong et al. MACROMOLECULAR RAPID COMMUNICATIONS
- Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies
- (2013) Lindsey M. Pujanauski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
- (2010) Bart R. Anderson et al. NUCLEIC ACIDS RESEARCH
- S1P1 Receptor Signaling Overrides Retention Mediated by Gαi-Coupled Receptors to Promote T Cell Egress
- (2008) Trung H.M. Pham et al. IMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started